Otilax (Otilonium Bromide)

Otilonium bromide, the active ingredient in Otilax, is an antispasmodic presented as a 20 mg tablet for oral use. It relieves abdominal cramping and discomfort associated with functional bowel disorders, particularly irritable‑bowel syndrome, in adult patients.

GNH USA supplies Otilax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Otilax is an antispasmodic that acts on smooth‑muscle activity within the gastrointestinal tract. - Irritable‑Bowel Syndrome (IBS): Reduces abdominal pain and cramping associated with IBS. - Functional Bowel Disorder: Improves bowel habit regularity and lessens discomfort. - Spastic Colon: Relieves colonic spasm and associated urgency. - Chronic Diarrhoea: Helps control stool frequency and urgency. - Abdominal Pain of Unknown Origin: Provides symptomatic relief when other causes have been excluded.

Otilax may cause adverse reactions, most of which are mild and reversible.

Common Side Effects: - Dry mouth - Nausea - Headache - Dizziness - Constipation

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Cardiac arrhythmia - Hepatotoxicity - Persistent severe constipation - Urinary retention

When prescribing Otilax, clinicians should consider several safety aspects. - Pregnancy: Use only if clearly needed. - Breastfeeding: Caution due to potential excretion. - Renal Impairment: Adjust dose if severe renal dysfunction. - Hepatic Impairment: Use with caution. - Drug Interactions: Review review  - Store at below  :    

Otilax  

---